This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          

Search results for "" (5922)


 
Higher lipoprotein A in hypertensives increases risk of adverse cardiovascular events
Drinking coffee and tea significantly reduces cardiovascular disease mortality
Meet the Expert: Philip Mease on psoriatic arthritis
Vaccination found to reduce risk of post-COVID-19 condition
CHMP recommends Enhertu for HER2-low breast cancer treatment
Significant placebo response to pain in cannabinoid clinical trials
Elranatamab induces durable clinical response in relapsed multiple myeloma
mRNA-4157/V940 vaccine effective in advanced melanoma
Tafasitamab shows best efficacy in refractory diffuse large B-cell lymphoma
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Cannabidiol of no additional value for symptom distress reduction in advanced cancer
Review suggests GLP1 agonists offer similar glycaemic control to bariatric surgery
Aprocitentan superior to placebo in resistant hypertension
Highly purified EPA reduces adverse cardiovascular events in at-risk patients
Medical marijuana reduces opiate use among cancer patients
PCSK9 inhibitor persistence in FH high in clinical practice
AI model predicts CVD risk from single chest radiograph
Higher liver stiffness persists several months after COVID-19 infection
Enlarged perivascular spaces revealed by MRI in migraine sufferers
Donanemab provides greater brain amyloid clearance than aducanumab in early Alzheimer’s
Higher level of advanced colorectal cancer diagnosed during COVID-19
MRI study suggest NSAIDs may worsen arthritis inflammation
The Covid-19 response across Europe
Healthcare in Europe: A review of healthcare data before Covid-19
Higher acetylcholinesterase activity associated with delirium during critical illness
Deferiprone treatment worsens Parkinson’s disease progression
Tisagenlecleucel effectiveness in paediatric leukaemia persists beyond 3 years

×